Drax Group (LON:DRX) has added greater diversity and new long-term options to its UK power portfolio following the acquisition of Bluefield Solar Investment Fund, highlighted in the latest research note..
India’s smart meter rollout is moving into a larger execution phase, expanding demand across metering hardware, communications, software and digital grid services...
Verici Dx has published analysis showing its PTRA kidney transplant risk test could generate more than $191 million in US healthcare savings over two years...
GB Group now expects FY27 group revenue growth of 1–3% after higher-than-expected customer volume attrition in its Americas Identity business. Adjusted operating profit margin is expected to be approximately 21%...
Diversified Energy has confirmed early-stage discussions regarding a possible acquisition of Birch Resources. No agreement has been reached, and there is no certainty that a transaction will proceed...
RTW Biotech Opportunities reported a July NAV of $2.82 per share, down 1.6% for the month, compared with declines of 1.7% for the Nasdaq Biotech Index and 4.4% for the..
Touchstone Exploration reported stronger second-quarter funds flow from operations and net income, alongside production, financing and operational progress...
India’s smart meter rollout is moving into a larger execution phase, expanding demand across metering hardware, communications, software and digital grid services...
Verici Dx has published analysis showing its PTRA kidney transplant risk test could generate more than $191 million in US healthcare savings over two years...
GB Group now expects FY27 group revenue growth of 1–3% after higher-than-expected customer volume attrition in its Americas Identity business. Adjusted operating profit margin is expected to be approximately 21%...
Diversified Energy has confirmed early-stage discussions regarding a possible acquisition of Birch Resources. No agreement has been reached, and there is no certainty that a transaction will proceed...
RTW Biotech Opportunities reported a July NAV of $2.82 per share, down 1.6% for the month, compared with declines of 1.7% for the Nasdaq Biotech Index and 4.4% for the Russell 2000 Biotech Index. Since launch, NAV per share has delivered 15.3% annualised performance...
Touchstone Exploration reported stronger second-quarter funds flow from operations and net income, alongside production, financing and operational progress...
